JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB184948

Anti-TGF beta Receptor II 抗体 [EPR14673]

Anti-TGF beta Receptor II antibody [EPR14673]

Be the first to review this product! Submit a review

|

(33 Publications)

Rabbit Recombinant Monoclonal TGF beta Receptor II antibody. Suitable for WB and reacts with Human samples. Cited in 33 publications.

別名を表示する

TGF-beta receptor type-2, TGFR-2, TGF-beta type II receptor, Transforming growth factor-beta receptor type II, TGF-beta receptor type II, TbetaR-II, TGFBR2

3 Images
Western blot - Anti-TGF beta Receptor II antibody [EPR14673] (AB184948)
  • WB

Supplier Data

Western blot - Anti-TGF beta Receptor II antibody [EPR14673] (AB184948)

ab184948 was shown to react with TGFBR2 in wild-type A549 cells in Western blot with loss of signal observed in TGFBR2 knockout cell line ab261863. Wild-type A549 and TGFBR2 knockout cell lysates were subjected to SDS-PAGE. Membranes were blocked in 5% milk in TBST for 1 hr before incubation with ab184948 overnight at 4 °C at a 1/1000 dilution. Blots were incubated with secondary antibodies at 0.2 µg/mL before imaging.

This data was provided by YCharOS Inc., an open science company with the mission of characterizing commercially available antibody reagents for all human proteins. Abcam and YCharOS are working together to help address the reproducibility crisis by enabling the life science community to better evaluate commercially available antibodies.

All lanes:

Western blot - Anti-TGF beta Receptor II antibody [EPR14673] (ab184948) at 1/1000 dilution

Lane 1:

Wild-type A549 lysate at 30 µg

Lane 2:

TGFBR2 knock-out A549 at 30 µg

Lane 2:

Western blot - Human TGFBR2 (TGF beta Receptor II) knockout A549 cell line (<a href='/products/cell-lines/human-tgfbr2-tgf-beta-receptor-ii-knockout-a549-cell-line-ab261863'>ab261863</a>)

Lane 2:

Western blot - Human TGFBR2 (TGF beta Receptor II) knockout A549 cell lysate (<a href='/products/cell-lysates/human-tgfbr2-tgf-beta-receptor-ii-knockout-a549-cell-lysate-ab261672'>ab261672</a>)

Observed band size: 66-95 kDa

false

Western blot - Anti-TGF beta Receptor II antibody [EPR14673] (AB184948)
  • WB

Lab

Western blot - Anti-TGF beta Receptor II antibody [EPR14673] (AB184948)

Lanes 1 - 4 : Merged signal (red and green). Green - ab184948 observed at 80 kDa. Red - loading control, ab8245, observed at 37 kDa.

ab184948 was shown to specifically react with in wild-type A549 cells as signal was lost in TGFBR2 knockout cell line ab261863 (knockout cell lysate ab261672). Wild-type and TGFBR2 knockout samples were subjected to SDS-PAGE. ab184948 and ab8245 (Mouse anti-GAPDH loading control) were incubated overnight at 4°C at 1/2000 dilution and 1/10000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed ab216773 and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed ab216776 secondary antibodies at 1/10000 dilution for 1 hour at room temperature before imaging.

All lanes:

Western blot - Anti-TGF beta Receptor II antibody [EPR14673] (ab184948) at 1/2000 dilution

Lane 1:

Wild-type A549 (Human lung carcinoma cell line) whole cell lysate at 20 µg

Lane 2:

TGFBR2 knockout A549 (Human lung carcinoma cell line) whole cell lysate at 20 µg

Lane 2:

Western blot - Human TGFBR2 (TGF beta Receptor II) knockout A549 cell line (<a href='/products/cell-lines/human-tgfbr2-tgf-beta-receptor-ii-knockout-a549-cell-line-ab261863'>ab261863</a>)

Lane 3:

HepG2 (Human liver hepatocellular carcinoma cell line) whole cell lysate at 20 µg

Lane 4:

HT-1080 whole cell lysate at 20 µg

Predicted band size: 65 kDa

Observed band size: 80 kDa

false

Western blot - Anti-TGF beta Receptor II antibody [EPR14673] (AB184948)
  • WB

Supplier Data

Western blot - Anti-TGF beta Receptor II antibody [EPR14673] (AB184948)

All lanes:

Western blot - Anti-TGF beta Receptor II antibody [EPR14673] (ab184948) at 1/5000 dilution

Lane 1:

HepG2 cell lysate at 20 µg

Lane 2:

A549 cell lysate at 20 µg

Secondary

All lanes:

Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated at 1/1000 dilution

Predicted band size: 65 kDa

false

関連する標識済み抗体及び組成の異なる製品 (1)

  • Carrier free

    Anti-TGF beta Receptor II antibody [EPR14673] - BSA and Azide free

Key facts

宿主種

Rabbit

クローン性

Monoclonal

クローン番号

EPR14673

アイソタイプ

IgG

キャリアフリー

No

交差種

Human

アプリケーション

WB

applications

免疫原

The exact immunogen used to generate this antibody is proprietary information.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000 - 1/10000", "WB-species-notes": "<p></p>" } } }

製品の詳細

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

出荷温度及び保存条件

製品の状態
Liquid
精製方法
Affinity purification Protein A
バッファー組成
pH: 7.2 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
出荷温度
Blue Ice
短期保存期間
1-2 weeks
短期保存温度
+4°C
長期保存温度
-20°C
分注に関する情報
Upon delivery aliquot
保管に関する情報
Avoid freeze / thaw cycle

製品プロトコール

For this product, it's our understanding that no specific protocols are required. You can visit:

ターゲットの情報

Transmembrane serine/threonine kinase forming with the TGF-beta type I serine/threonine kinase receptor, TGFBR1, the non-promiscuous receptor for the TGF-beta cytokines TGFB1, TGFB2 and TGFB3. Transduces the TGFB1, TGFB2 and TGFB3 signal from the cell surface to the cytoplasm and thus regulates a plethora of physiological and pathological processes including cell cycle arrest in epithelial and hematopoietic cells, control of mesenchymal cell proliferation and differentiation, wound healing, extracellular matrix production, immunosuppression and carcinogenesis. The formation of the receptor complex composed of 2 TGFBR1 and 2 TGFBR2 molecules symmetrically bound to the cytokine dimer results in the phosphorylation and activation of TGFBR1 by the constitutively active TGFBR2. Activated TGFBR1 phosphorylates SMAD2 which dissociates from the receptor and interacts with SMAD4. The SMAD2-SMAD4 complex is subsequently translocated to the nucleus where it modulates the transcription of the TGF-beta-regulated genes. This constitutes the canonical SMAD-dependent TGF-beta signaling cascade. Also involved in non-canonical, SMAD-independent TGF-beta signaling pathways.. Isoform 1. Has transforming growth factor beta-activated receptor activity.. Isoform 2. Has transforming growth factor beta-activated receptor activity.. Isoform 3. Binds TGFB1, TGFB2 and TGFB3 in the picomolar affinity range without the participation of additional receptors. Blocks activation of SMAD2 and SMAD3 by TGFB1.
See full target information TGFBR2

文献 (33)

Recent publications for all applications. Explore the full list and refine your search

Journal of tissue engineering 16:20417314251357752 PubMed40755460

2025

GDF15 promotes osteogenic differentiation of human dental pulp stem cells by activating the TGF-β/SMAD signaling pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Pingmeng Deng,Bin Yang,Chuling Huang,Yuejia Li,Ziyi Mei,Yong Li,Jie Li

Cell communication and signaling : CCS 23:326 PubMed40629347

2025

Artificial intelligence-driven discovery of YH395A: A novel TGFβR1 inhibitor with potent anti-tumor activity against triple-negative breast cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Jun Ling,Jie Zhang,Baozhen Wang,Jing FengSong,Tao Li,Jing Chen

iScience 27:111502 PubMed39758992

2025

Reduced lung metastasis in endothelial cell-specific transforming growth factor β type II receptor-deficient mice with decreased CD44 expression.

Applications

Unspecified application

Species

Unspecified reactive species

Kako Hanada,Yuki Saito,Takahiro Takagi,Mitsuki Go,Yota Nakano,Toshihiko Inagawa,Hideyo Hirai,Marcus Fruttiger,Susumu Itoh,Fumiko Itoh

Cell reports methods 4:100857 PubMed39260365

2024

An improved approach to generate IL-15/TGFβR2 iPSC-derived natural killer cells using TALEN.

Applications

Unspecified application

Species

Unspecified reactive species

An-Ping Chen,Peng Gao,Liang Lin,Preeti Ashok,Hongzhi He,Chao Ma,David Li Zou,Vincent Allain,Alex Boyne,Alexandre Juillerat,Philippe Duchateau,Armin Rath,Daniel Teper,Antonio Arulanandam,Hao-Ming Chang,Justin Eyquem,Wei Li

Genes 15: PubMed39062724

2024

Expression Patterns of , , and Reveal Insights into Heterosis for Growth of Hybrid Offspring between and .

Applications

Unspecified application

Species

Unspecified reactive species

Xinran Du,Yue Zhao,Jingbo Li,Wenli Xie,Linna Lyu,Shuyin Chen,Chaofeng Jia,Jie Yan,Peng Li

PLoS computational biology 20:e1012072 PubMed38753874

2024

Liebig's law of the minimum in the TGF-β/SMAD pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Yuchao Li,Difan Deng,Chris Tina Höfer,Jihye Kim,Won Do Heo,Quanbin Xu,Xuedong Liu,Zhike Zi

Molecular neurodegeneration 19:1 PubMed38172904

2024

Proteo-genomics of soluble TREM2 in cerebrospinal fluid provides novel insights and identifies novel modulators for Alzheimer's disease.

Applications

Unspecified application

Species

Unspecified reactive species

Lihua Wang,Niko-Petteri Nykänen,Daniel Western,Priyanka Gorijala,Jigyasha Timsina,Fuhai Li,Zhaohua Wang,Muhammad Ali,Chengran Yang,Menghan Liu,William Brock,Marta Marquié,Mercè Boada,Ignacio Alvarez,Miquel Aguilar,Pau Pastor,Agustín Ruiz,Raquel Puerta,Adelina Orellana,Jarod Rutledge,Hamilton Oh,Michael D Greicius,Yann Le Guen,Richard J Perrin,Tony Wyss-Coray,Angela Jefferson,Timothy J Hohman,Neill Graff-Radford,Hiroshi Mori,Alison Goate,Johannes Levin,Yun Ju Sung,Carlos Cruchaga

Cell death & disease 14:826 PubMed38092723

2023

The chromatin remodeling protein BRG1 regulates HSC-myofibroblast differentiation and liver fibrosis.

Applications

Unspecified application

Species

Unspecified reactive species

Yuwen Zhu,Aoqi Kang,Yameng Kuai,Yan Guo,Xiulian Miao,Li Zhu,Ming Kong,Nan Li

Oncology reports 49: PubMed36562379

2022

Macrophage renewal modes affect acquired resistance to gefitinib in EGFR‑mutant lung cancer PC‑9 cells.

Applications

Unspecified application

Species

Unspecified reactive species

Baoxia Zhao,Yan Zhang,Shen Lu,Mei Li

Nature communications 13:4461 PubMed35915084

2022

Breast cancer cell-derived extracellular vesicles promote CD8 T cell exhaustion via TGF-β type II receptor signaling.

Applications

Unspecified application

Species

Unspecified reactive species

Feng Xie,Xiaoxue Zhou,Peng Su,Heyu Li,Yifei Tu,Jinjin Du,Chen Pan,Xiang Wei,Min Zheng,Ke Jin,Liyan Miao,Chao Wang,Xuli Meng,Hans van Dam,Peter Ten Dijke,Long Zhang,Fangfang Zhou
View all publications

Abcam product promise

当社は、高品質な試薬を通じてお客様の研究を力強くサポートすることをお約束いたします。ご使用いただく各段階で、常にお客様をサポートできる体制を整えております。万が一、製品が期待通りに機能しない場合は、「Abcam Product Promise」による当社保証制度に基づき、安心してご利用いただけます。
保証に関する詳細については利用規約をご確認ください。

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com